$heff's $tation of $tocks & $olid DD

[gambler2075]

I will say that $SPHS has held up suprisingly well compared to the bio carnage we have had over the past couple of weeks... I still think it is insultingly undervalued for having a market cap of ~15 million, with an impending phase 3 result coming in Q4.

IMO, Dan Ward had some great points in his Nov article for seekingalpha.

http://seekingalpha.com/article/2702535-sophiris-bio-upcoming-catalysts-present-very-attractive-upside

For full disclosure, he has become bearish after the interim results in December, but the stock has rallied over 100% from those lows, so IMO it suggests that perhaps the final P3 results will be a surprise. I look back on the many, many times that a stock has had bad prelim/interim results, and then positive final results, and IMO, this is one of these cases.

That being said, I do have a substantial position here so I could be biased. Do your own DD and, as always, my posts are only my opinion and not investment advice.

g